Topeka Hospital, LLC

Topeka Hospital, LLC is a for-profit hospital located in Topeka, Kansas that has established itself as a specialized supplier of radiopharmaceuticals to the federal government, primarily serving the Department of Veterans Affairs. Registered in SAM.gov since February 2021, the entity operates as a limited liability corporation and has developed a sustained federal contracting relationship focused on supporting medical imaging and diagnostic services within the Veterans Health Administration system.

Through its federal contract awards, Topeka Hospital, LLC has consistently supplied radiopharmaceuticals to the Department of Veterans Affairs, specifically through the Veterans Integrated Service Network 15 (VISN 15), which serves veterans in eastern Kansas and surrounding areas. The contractor has received multiple delivery orders under indefinite delivery contracts, ranging in value from $128,342.31 to $970,000.00, all structured as firm fixed price contracts with no set-aside designations. These delivery orders have been issued annually from September 2021 through September 2025, with each contract bearing descriptions such as "RADIOPHARMACEUTICALS" or "RADIOPHARMACEUTICALS OY2 RENEWAL." The radiopharmaceuticals supplied support nuclear medicine diagnostics and imaging services at VA medical centers throughout the VISN 15 region, enabling specialized diagnostic imaging capabilities for the veteran population. All contract work is performed in Topeka, Kansas, and none of the contract awards utilize any small business or socioeconomic set-aside provisions.

Topeka Hospital, LLC has also participated in federal grant work as a sub-award recipient under grants administered by the University of Kansas Medical Center Research Institute, Inc. The entity has received two federal grant sub-awards, dated February 5, 2025 and February 22, 2023, both related to clinical research partnerships. Under these sub-awards, Topeka Hospital, LLC serves as an MCA (Midwest Center for Appropriate Care or similar designation) Clinical Research Partner and designates mutually agreeable staffing levels to manage the clinical and administrative aspects of TRAILS (a clinical research initiative) as part of a research collaboration between the parties. These grant sub-awards demonstrate the hospital's involvement in clinical research and administrative support activities beyond its primary radiopharmaceutical supply function.

Topeka Hospital, LLC holds two active Indefinite Delivery Contracts with the Department of Veterans Affairs through VISN 15. The primary IDC, awarded on September 23, 2022, carries a ceiling value of $5,672,148.70 and extends through September 22, 2026, serving as the vehicle through which multiple radiopharmaceutical delivery orders have been issued. This single-award contract allows VISN 15 to procure radiopharmaceuticals on an as-needed basis for VA medical centers in the eastern Kansas region. Additionally, the contractor maintains an older IDC awarded on April 1, 2021, with a ceiling value of $927,248.06 and an ultimate completion date of September 22, 2022, which also provided a framework for radiopharmaceutical procurement. Both IDCs are structured without set-aside provisions and reflect the VA's reliance on Topeka Hospital, LLC as a consistent supplier of specialized medical products essential to veteran healthcare delivery.